SCHEMBL3984992

SCHEMBL3984992

N#Cc1c(O)ccc(C(=O)OC(=O)c2occ(COC(=O)NCCc3ccccc3)c2-c2ccccc2)c1C(=O)NN

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 5/20 0.35
TP53 P04637 4/20 0.35
MEN1 O00255 4/20 0.35
MAPT P10636 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPK1 P28482 4/20 0.35
EGFR P00533 4/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
ALOX15 P16050 3/20 0.35
ALOX12 P18054 3/20 0.35
RECQL P46063 3/20 0.35
BLM P54132 3/20 0.35
HSD17B10 Q99714 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
GMNN O75496 2/20 0.35
ERBB2 P04626 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977528 0.88 GAA (0.35) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL4248617 0.87 ALDH1A1 (0.33) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL3978288 0.84 ALDH1A1 (0.34) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL3974971 0.84 ALDH1A1 (0.38) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL3981371 0.82 TACR1 (0.38) KDM4EALDH1A1HPGDPOLBGAA
SCHEMBL3975937 0.81 ALDH1A1 (0.36) KDM4EALDH1A1HPGDMEN1MAPT
SCHEMBL3981057 0.79 GPR52 (0.31)
SCHEMBL3983320 0.79 TP53 (0.43) TP53KMT2AHSD17B10SMN1; SMN2HTT
SCHEMBL3980870 0.79 IKBKB (0.34) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL4282780 0.78 GAA (0.32) KDM4EALDH1A1HPGDMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 KDM4E 2769/4885ALDH1A1 1389/4885HPGD 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.